In an interview on Unomattina Estate, Gabriele Ferrieri, President of ANGI, explores the challenges and opportunities of artificial intelligence in Italy, highlighting the importance of harmonizing regulations and increasing investments.
“Artificial intelligence is the ability of a machine to display human capabilities such as reasoning, learning, planning and creativity. AI works thanks to the use of two very important elements: data and algorithm. Data is the information that feeds AI and algorithm are the instructions that, through programming, we define for a computer system”. This is what Gabriele Ferrieri, President of ANGI – National Association of Young Innovators, said on Unomattina Estate on Rai 1. President Ferrieri, former ForbesU30 and AI expert, responded to the question on the regulatory issue and the regulation of artificial intelligence by journalist and co-host Greta Mauro, also launching an appeal to the institutions and the Meloni Government: “The European Parliament passed the AI Act last March and Italy, just over a month later, immediately prepared its own national legislation that takes the key points from European legislation and on this I must say that we have been particularly far-sighted in approaching the topic of artificial intelligence from a regulatory point of view. There are three key elements in particular. The ethical use of artificial intelligence also linked to the healthcare sector, the approach of democratizing these tools to ensure that they can be of effective support to citizens, for example one of the themes that has been relaunched is that of the electronic health record with the aim of being able to have access from any hospital point in Italy and above all to be able to have a real-time vision of everything that has been and is the patient’s situation to the attending physician or if there is an emergency to be able to act based on what have been the case histories of the person present there. Last but not least is the issue of data security: imagine if this data were used inappropriately, for example for speculative or commercial purposes by large pharmaceutical companies.
“However, it is necessary to remember that there must be, in our opinion, an approach that harmonizes such regulation to ensure that the regulations are there but that they represent a slowdown in terms of investments in the technological field, this is also an appeal from the National Association of Young Innovators that we would like to give”. Ferrieri concludes.
Image generated with DALL-E
#Artificial #Intelligence #Regulation #Critical #Issues #Italian #System
